BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2015
View Archived Issues
FDA grants rituximab orphan drug status for pemphigus vulgaris
Read More
Pluristem and Hadassah Medical Center report data from preclinical PLX-R18 study
Read More
New grant to support biomarker-led development of irofulven for mCRPC
Read More
Phase II results presented for a urothelial carcinoma combination therapy
Read More
Novel AR and CYP17A1 dual inhibitor shows significant antitumor activity
Read More
Vanda reports topline phase II results for tradipitant
Read More
EC-1169 drug conjugate is safe in mCRPC patients
Read More
[68Ga]PSMA PET/CT shows promise for detecting prostate cancer recurrence
Read More
Sirona Biochem reports preclinical toxicology results for SBM-TFC-039
Read More
Enrollment begins in phase I/IIa trial of AST-OPC1 in complete cervical spinal cord injury
Read More
Arrowhead Research acquires Novartis' RNAi R&D portfolio
Read More
Spectrum Pharmaceuticals in-licenses poziotinib from Hanmi Pharmaceuticals
Read More
Galapagos patents new ephrin inhibitors
Read More
Novartis discloses new MEK inhibitors
Read More
arGEN-X exercises option to license antibody candidate for cancer immunotherapy
Read More
Sanofi presents new anti-PAI-1 MAbs
Read More
Janssen describes Ca(v) 2.2 channel blockers
Read More
Bristol-Myers Squibb reports novel GR and AP-1 modulators
Read More
Blueprint Medicines and Alexion partner to develop kinase-targeting drugs for rare genetic disease
Read More
Grifols agrees to make major equity investment in Alkahest
Read More
Oraya IRay Radiotherapy system receives CE Mark extension for choroidal metastases
Read More
Medtronic invests in Flex Pharma IPO
Read More
Calithera gains worldwide license to TransTech's hexokinase-2 inhibitors
Read More
Quantum Genomics initiates phase IIa trial of QGC-001 for hypertension
Read More
Novel DNA-based therapy shows efficacy for advanced ovarian cancer treatment
Read More
AstraZeneca and University of Cambridge collaborate on start-up venture program
Read More